PICOS criteria for the SLR. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

PRISMA flow chart. by Filip Stanicic (17808254)

Subjects:

Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Subjects:

Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization by figshare admin karger (2628495)

“…Participants were categorized by LVEDD change from baseline: No Change (<5 mm), Decreased (≥5 mm), and Increased (≥5 mm). Results: A decrease in LVEDD was observed in 24% of participants (mean change -9±3 mm) and was significantly associated with older age, female sex, decreased volumes, concentric remodeling and diastolic dysfunction. …”

Intra- and inter-observer agreement of all outcome measures, which were recorded on 26 video clips (excluding vocalisations, elimination behaviour and startle responses, which were... by Sara Hintze (3216885)

Subjects:

Effect of advanced chelate technology-based trace minerals on serum antioxidant status and hormone profile observed in broiler chickens challenged with heat stress. by Taher Mohammadizad (19786989)

Data from qPCR analysis of hemolymph from included clams. by Rachael M. Giersch (22331947)

Subjects:

Agreement between microscopy and qPCR analysis of MarBTN progression. by Rachael M. Giersch (22331947)

Subjects:

Verification of PLUS CYCLE^® signals during presumed sleep periods. by Akihiro Ohnishi (10989900)

Subjects:

Data from qPCR analysis of eDNA and matching hemolymph timepoints. by Rachael M. Giersch (22331947)

Subjects:

Characteristics and outcomes from clams with MarBTN and control healthy clams. by Rachael M. Giersch (22331947)

Subjects:

Anecdotal case of regression in a clam with naturally acquired BTN. by Rachael M. Giersch (22331947)

Subjects:

MarBTN-specific eDNA detection in each clam that was followed for MarBTN in hemolymph and eDNA. by Rachael M. Giersch (22331947)

Subjects:

A summary of the dogs used to detect sleep disturbances with PLUS CYCLE^®. by Akihiro Ohnishi (10989900)

Subjects: